Literature DB >> 16607677

Molecular biology of squamous cell carcinoma of the anus.

P Gervaz1, B Hirschel, P Morel.   

Abstract

BACKGROUND: Squamous cell carcinoma of the anal canal provides a model for studying the contribution of human papillomavirus (HPV) and human immunodeficiency virus (HIV) infection to the development of neoplasia. This paper reviews the existing literature relating to the molecular biology of anal squamous cell carcinoma and proposes a theory of pathogenesis.
METHODS: A Medline literature search was performed to identify English articles on the pathogenesis of squamous cell carcinoma of the anus; further articles were obtained from the references quoted in the literature initially reviewed.
RESULTS: HPV infection and subsequent HPV DNA integration are necessary, but not sufficient, to cause cancer progression. Loss of heterozygosity at 11q23 is the most consistent genomic change observed. Loss of heterozygosity at 17p, 18q and 5q is frequently observed in tumours of HIV-negative patients, but not in those of HIV-positive patients. Current data suggest that mutations in p53, DCC and APC tumour suppressor genes contribute to the stepwise progression of anal squamous cell carcinoma in immunocompetent individuals.
CONCLUSION: In comparison with immunocompetent individuals, HIV-positive patients have persistent HPV infection in the anal canal. In this population, microsatellite instability, rather than chromosomal instability, appears to be a preferred pathway for rapid progression towards invasive carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16607677     DOI: 10.1002/bjs.5376

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  14 in total

Review 1.  Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA).

Authors:  Christian Marin-Muller; Min Li; Changyi Chen; Qizhi Yao
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

Review 2.  Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.

Authors:  Guillaume Klausner; Eivind Blais; Raphaël Jumeau; Julian Biau; Mailys de Meric de Bellefon; Mahmut Ozsahin; Thomas Zilli; Raymond Miralbell; Juliette Thariat; Idriss Troussier
Journal:  Med Oncol       Date:  2018-08-20       Impact factor: 3.064

3.  Anal cancer - a review.

Authors:  Sajad Ahmad Salati; Azzam Al Kadi
Journal:  Int J Health Sci (Qassim)       Date:  2012-06

4.  Anal squamous cell carcinoma in the HIV-positive patient.

Authors:  Deborah Nagle
Journal:  Clin Colon Rectal Surg       Date:  2009-05

Review 5.  Squamous cell carcinoma of the anus-an opportunistic cancer in HIV-positive male homosexuals.

Authors:  Pascal Gervaz; Alexandra Calmy; Ymer Durmishi; Abdelkarim S Allal; Philippe Morel
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

6.  A mouse model for human anal cancer.

Authors:  Marie K Stelzer; Henry C Pitot; Amy Liem; Johannes Schweizer; Charles Mahoney; Paul F Lambert
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-06

7.  Prevalence of human papillomavirus infection of the anal canal in women: A prospective analysis of high-risk populations.

Authors:  Bernd P Kost; Jörg Hofmann; Susanne Stoellnberger; Florian Bergauer; Thomas Blankenstein; Irene Alba-Alejandre; Angela Stein; Claudia Stuckart; Katharina Weizsäcker; Ioannis Mylonas; Sven Mahner; Andrea Gingelmaier
Journal:  Oncol Lett       Date:  2017-02-10       Impact factor: 2.967

8.  Anal dysplasia screening: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2007-06-01

Review 9.  Diagnosis and management of anal cancer.

Authors:  Pascal Gervaz; Nicolas Buchs; Philippe Morel
Journal:  Curr Gastroenterol Rep       Date:  2008-10

10.  Potential role of human papilloma virus in the pathogenesis of gastric cancer.

Authors:  Miroslaw Snietura; Dariusz Waniczek; Wojciech Piglowski; Agnieszka Kopec; Ewa Nowakowska-Zajdel; Zbigniew Lorenc; Malgorzata Muc-Wierzgon
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.